Research Department of Chemistry, SRM University, Ramapuram, Chennai, Tamil Nadu, India.
Acta Pharm. 2013 Jun;63(2):253-64. doi: 10.2478/acph-2013-0018.
2 The present work deals with the synthesis of some novel heterocyclic compounds such as benzoxazoles , 7, 13 and 19, imidazoles 3, 8, 14 and 20, benzimidazoles 4, 9, 15 and 21, and tetrazoles 10, 16, and 22. The synthesized compounds were characterized by IR, 1H NMR, mass spectrometry and elemental analysis. The compounds were evaluated for cytotoxicity against human cancer cell lines such as MCF-7 (breast cancer) and HT-29 (colon cancer) by the MTT assay method. Among the tested compounds, 4,4'-sulfonylbis(N-(2-(1H-benzo[d]imidazol- -2-yl)ethyl)aniline (9), N-bis(2-(benzo[d]oxazol-2-yl)-ethyl)- 6-phenyl-1,3,5-triazine-2,4-diamine (13), N-bis(2-(1H-benzo[ d]imidazol-2-yl)ethyl)-6-phenyl-1,3,5-triazine-2,4-diamine (15) and N-tris(2-1H-benzo[d]imidazol-2-yl)ethyl)- 1,3,5-triazine-2,4,6-triamine (21) showed potent cytotoxicity.
2 本工作涉及一些新型杂环化合物的合成,如苯并恶唑、7、13 和 19、咪唑、3、8、14 和 20、苯并咪唑、4、9、15 和 21 以及四唑、10、16 和 22。合成的化合物通过红外光谱、1H NMR、质谱和元素分析进行了表征。通过 MTT 测定法评估了化合物对 MCF-7(乳腺癌)和 HT-29(结肠癌)等人类癌细胞系的细胞毒性。在所测试的化合物中,4,4'-磺酰基双(N-(2-(1H-苯并[d]咪唑-2-基)乙基)苯胺)(9)、N-双(2-(苯并[d]恶唑-2-基)-乙基)-6-苯基-1,3,5-三嗪-2,4-二胺(13)、N-双(2-(1H-苯并[d]咪唑-2-基)乙基)-6-苯基-1,3,5-三嗪-2,4-二胺(15)和 N-三(2-1H-苯并[d]咪唑-2-基)乙基)-1,3,5-三嗪-2,4,6-三胺(21)表现出很强的细胞毒性。